Recital 7, Regulation (EU) 2024/3169

In forcesince 18 Dec 2024

The HTA secretariat should inform the European Medicines Agency of granted requests for joint scientific consultation on medicinal products to be conducted in parallel with the scientific advice. Where joint scientific consultations on medicinal products are conducted in parallel with the scientific advice, the HTA secretariat and the European Medicines Agency should exchange the appropriate information to ensure that the parallel consultations have synchronised timing.